A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer
NCT05934461
·
clinicaltrials.gov ↗
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
The Primary Study Metric is Progression-free Survival (PFS)
Sponsor
Laibin People's Hospital